Eargo (NASDAQ:EAR) and ReWalk Robotics (NASDAQ:RWLK) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations.
This is a breakdown of recent ratings for Eargo and ReWalk Robotics, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Institutional and Insider Ownership
3.8% of ReWalk Robotics shares are owned by institutional investors. 6.9% of ReWalk Robotics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Eargo and ReWalk Robotics’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|ReWalk Robotics||$4.87 million||9.30||-$15.55 million||($2.70)||-0.68|
Eargo has higher earnings, but lower revenue than ReWalk Robotics.
This table compares Eargo and ReWalk Robotics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Eargo, Inc., a consumer-focused medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions. It offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. The company is also developing ReWalk Restore, a soft suit exoskeleton for rehabilitation of individuals suffering from a stroke. It markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.
Receive News & Ratings for Eargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eargo and related companies with MarketBeat.com's FREE daily email newsletter.